Inflammation, fibrosis, cirrhosis and hepatocellular carcinoma (HCC) risk.
Glyco Liver Profile enables patient risk assessment, monitoring, diagnosis and 5-year prediction of hepatocellular carcinoma (HCC) development using four glycan biomarkers which together provide a clear insight into liver health.
The Glyco Liver Profile is a unique, non-invasive test that provides the clinician with a full picture of liver health regardless of aetiology — all from a single blood sample.
This innovative test addresses the medical and economic costs of chronic liver disease — accounting for approximately 2% of deaths annually — streamlining patient stratification and risk assessment, and improving clinical management and treatment outcomes.
Glyco Liver Profile joins a range of existing tests running on our fully-automated V8 NEXUS capillary electrophoresis system.